Lysine 2-hydroxyisobutyrylation proteomics reveals protein modification alteration in the actin cytoskeleton pathway of oral squamous cell carcinoma

被引:16
|
作者
Zhang, Zeyu [1 ,2 ]
Xie, Hongliang [1 ]
Zuo, Wenxin [1 ]
Tang, Jianming [1 ]
Zeng, Zhipeng [1 ]
Cai, Wanxia [1 ]
Lai, Liusheng [3 ]
Lu, Yongpin [2 ]
Shen, Lingjun [2 ]
Dong, Xiangnan [2 ]
Yin, Lianghong [2 ]
Tang, Donge [1 ]
Dai, Yong [1 ,3 ]
机构
[1] Jinan Univ, Southern Univ Sci & Technol, Affiliated Hosp 1, Clin Med Coll 2,Shenzhen Peoples Hosp, CN-518020 Shenzhen 518020, Peoples R China
[2] Jinan Univ, Affiliated Hosp 1, Dept Nephrol & Blood Purificat, Guangzhou 510632, Peoples R China
[3] Southern Med Univ, Affiliated Hosp 924, Guangxi Key Lab Metab Dis Res, Guilin 541002, Guangxi, Peoples R China
关键词
Oral squamous cell carcinoma; Lysine; 2-hydroxyisobutyrylation; Post-translational modifications; Actin cytoskeleton; Mass spectrometry; NONMUSCLE MYOSIN IIA; MESENCHYMAL TRANSITION; DOWN-REGULATION; POOR-PROGNOSIS; CANCER; INVASION; PROLIFERATION; METASTASIS; EXPRESSION; MIGRATION;
D O I
10.1016/j.jprot.2021.104371
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
As the most commonplace malignant carcinoma in the oral cavity, oral squamous cell carcinoma (OSCC) is highly invasive and prone to recurrence. The nosogenesis of OSCC are affected by epigenetics. Recently, a newly-found post-translational modification of lysine, 2-hydroxyisobutylation (Khib), has been proved to play a critical role in biological regulation. However, no research has evaluated the mechanism of Khib in oral cancer. Here, we performed liquid chromatography-mass spectrometry-based quantitative proteomics combined with bioinformatics analysis to reveal and evaluate Khib protein alterations in OSCC. Numerous proteins in OSCC undergo up regulated modification of Khib. We quantified and identified 967 proteins with differential expression levels, and 617 2-hydroxyisobutylated proteins with 938 Khib sites. Among them, 125 proteins both differentially expressed and accompanied by obvious Khib modification were further identified and analyzed through KEGG-based and ingenuity pathway analysis (IPA). These proteins are enriched in the actin cytoskeleton regulatory pathway, and IPA predicted that they alter the state of actin aggregation and stability, hence impacting and regulating the actin cytoskeleton in OSCC. This is the first 2-hydroxyisobutylated modification proteomics performed for OSCC. Khib protein is significantly concentrated in the actin cytoskeleton regulatory pathway, indicating that this pathway may mediate the tumorigenesis or exacerbation of OSCC. Significance: This is the first study that revealed the alterations of Khib protein in oral squamous cell carcinoma through LC-MS/MS-based modified proteomic. Our data showed that the protein in the actin cytoskeleton regulatory pathway was underwent significant Khib modification and abundance changes. We applied predictive function in IPA software to analyze and clarify that the aggregation of actin and the regulation of actin stability that mediated by the actin cytoskeleton regulatory pathway may be the potential mechanism of the occurrence and development of oral squamous cell carcinoma. Our research broadens the understanding of the pathogenesis of oral squamous cell carcinoma and provides new insights for future research.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Cancerous Inhibitor of Protein Phosphatase 2A as a Molecular Marker for Aggressiveness and Survival in Oral Squamous Cell Carcinoma
    Alzahrani, Rajab
    Alrehaili, Amani A.
    Gharib, Amal F.
    Anjum, Farah
    Ismail, Khadiga A.
    Elsawy, Wael H.
    JOURNAL OF CANCER PREVENTION, 2020, 25 (01) : 21 - 26
  • [42] Clinical Significance and Prognostic Value of SOX2 Protein Expression in Patients With Oral Squamous Cell Carcinoma
    Ghazaghi, Faezeh
    Saffar, Hana
    Yazdani, Farzad
    Etebarian, Arghavan
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (09) : 700 - 705
  • [43] NEDD 4 binding protein 2-like 1 promotes cancer cell invasion in oral squamous cell carcinoma
    Tomonori Sasahira
    Miyako Kurihara
    Yukiko Nishiguchi
    Rina Fujiwara
    Tadaaki Kirita
    Hiroki Kuniyasu
    Virchows Archiv, 2016, 469 : 163 - 172
  • [44] NEDD 4 binding protein 2-like 1 promotes cancer cell invasion in oral squamous cell carcinoma
    Sasahira, Tomonori
    Kurihara, Miyako
    Nishiguchi, Yukiko
    Fujiwara, Rina
    Kirita, Tadaaki
    Kuniyasu, Hiroki
    VIRCHOWS ARCHIV, 2016, 469 (02) : 163 - 172
  • [45] Molecular Targeting of Her-2/neu Protein Is Not Recommended as an Adjuvant Therapy in Oral Squamous Cell Carcinoma and Oral Lichen Planus
    Kouhsoltani, Maryam
    Aghbali, Amirala
    Shokoohi, Behrooz
    Ahmadzadeh, Ronak
    ADVANCED PHARMACEUTICAL BULLETIN, 2015, 5 : 649 - 652
  • [46] OSR1 suppresses oral squamous cell carcinoma proliferation and migration via the AXIN2/β-catenin pathway
    Guo, Xintong
    Du, Xinyi
    Zhao, Gaoye
    Liu, Chongshen
    Gao, Jing
    Huang, Zunzhi
    Dong, Wei
    ORAL DISEASES, 2024,
  • [47] BST2 promotes growth and induces gefitinib resistance in oral squamous cell carcinoma via regulating the EGFR pathway
    Jin, Huang
    Zhang, Lianping
    Wang, Shufang
    Qian, Lei
    ARCHIVES OF MEDICAL SCIENCE, 2021, 17 (06) : 1772 - 1782
  • [48] MFAP2 promotes the progression of oral squamous cell carcinoma by activating the Wnt/β-catenin signaling pathway through autophagy
    Zhang, Hao
    Shen, Si
    Feng, Chong
    Chen, Gang
    Wang, Xinxing
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2023, 55 (09) : 1445 - 1455
  • [49] LncOCMRL1 promotes oral squamous cell carcinoma growth and metastasis via the RRM2/EMT pathway
    Lu, Nan
    Jiang, Qiming
    Xu, Tianshu
    Gao, Qiyuan
    Wang, Yuepeng
    Huang, Zixian
    Huang, Zhiquan
    Xu, Xiaoding
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2024, 43 (01)
  • [50] Recurrent coamplification of cytoskeleton-associated genes EMS1 and SHANK2 with CCND1 in oral squamous cell carcinoma
    Freier, K
    Sticht, C
    Hofele, C
    Flechtenmacher, C
    Stange, D
    Puccio, L
    Toedt, G
    Radlwimmer, B
    Lichter, P
    Joos, S
    GENES CHROMOSOMES & CANCER, 2006, 45 (02): : 118 - 125